USPTO serial 97623942
FOPAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 13, 2026
- Examiner
- ALLEN, BIANCA LEIGH
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with FOPAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Clementia Pharmaceuticals Inc.
Montreal, Quebec, CA
Clementia Pharmaceuticals Inc.
Montreal, Quebec, CA
Clementia Pharmaceuticals Inc.
Montreal, Quebec, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Makiko Coffland
Makiko Coffland CHRISTENSEN O'CONNOR JOHNSON KINDNESS1201 THIRD AVENUE, SUITE 3600SEATTLE, WA 98101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Maintaining a registry of patient data and medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment; conducting business and market research surveys in the fields of pharmaceuticals and clinical trials | ACTIVE | — |
| 042 | Providing a website featuring medical and scientific research educational information in the fields of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of Fibrodysplasia ossificans progressiva (FOP) disease and treatment | ACTIVE | — |
| 044 | Providing an online computer database featuring a compilation of medical information and patient records being medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment; medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment; medical assistance services, namely, providing support in the observation, monitoring, adherence and medical treatments on patients in the field of Fibrodysplasia ossificans progressiva (FOP) disease; health assessment services, namely, conducting health-related surveys and questionnaires that produce medical treatment information; conducting medical information surveys and questionnaires in the fields of disease and treatment, namely, conducting health surveys of patients with Fibrodysplasia ossificans progressiva (FOP) disease for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Clementia Pharmaceuticals Inc.
- Other trademarks owned by Clementia Pharmaceuticals Inc.
- Other trademarks owned by Clementia Pharmaceuticals Inc.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named FOPAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 13, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 25, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 25, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 19, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 31, 2026 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jul 24, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 22, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 22, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 22, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 22, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 15, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 15, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 15, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 19, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 19, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 19, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 23, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 23, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 22, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 26, 2026 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 26, 2026 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 26, 2026 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 5, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 4, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 4, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 4, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 3, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 3, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 2, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 14, 2025 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Apr 14, 2025 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 14, 2025 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Apr 11, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 7, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 7, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 7, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 10, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 10, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 10, 2024 | ALIE | ASSIGNED TO LIE | — |
| Apr 16, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 27, 2024 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Feb 27, 2024 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Feb 27, 2024 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 14, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 19, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 19, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 19, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 11, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 11, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 11, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 10, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 9, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 9, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 11, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 11, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 11, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 8, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 24, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 11, 2022 | NWAP | NEW APPLICATION ENTERED | — |